Cryptotanshinone Inhibits Lps-Induced Proinflammatory Mediators Via Tlr4 and Tak1 Signaling Pathway

Xin Li,Li-Hua Lian,Ting Bai,Yan-Ling Wu,Ying Wan,Wen-Xue Xie,Xuejun Jin,Ji-Xing Nan
DOI: https://doi.org/10.1016/j.intimp.2011.07.018
IF: 5.714
2011-01-01
International Immunopharmacology
Abstract:Cryptotanshinone (CTN), one of the major constituents of tanshinones, was investigated for anti-inflammatory activity in the murine macrophage cell line RAW 264.7. CTN inhibited the production of nitric oxide (NO) production, as well as expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2) in lipopolysaccharide (LPS)-stimulated macrophages. Since CTN was considered as inhibiting LPS-triggered phosphorylation of mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-κB activation, we consequently evaluated the expression of toll-like receptor 4 (TLR4) and CD14, as well as phosphorylation of TGF-β-activated kinase 1 (TAK1). CTN reduced the expression of CD14 and TLR4, and suppressed LPS-induced phosphorylation of TAK1. Furthermore, CTN significantly increased the survival rate against LPS challenge in D-galactosamine-sensitized mice, which was in line with in vitro results. These results suggested that CD14/TLR4 and TAK1 might be the potential molecular targets for addressing the protective effects of CTN on LPS-induced inflammatory effects in macrophages.
What problem does this paper attempt to address?